Advertisement
U.S. markets open in 1 hour 49 minutes

BerGenBio ASA (BGBIO.OL)

Oslo - Oslo Delayed Price. Currency in NOK
14.55+1.85 (+14.45%)
As of 01:26PM CET. Market open.
Full screen
Previous Close12.70
Open13.48
Bid14.55 x 0
Ask14.65 x 0
Day's Range13.34 - 15.67
52 Week Range5.62 - 35.80
Volume1,981,897
Avg. Volume274,281
Market Cap568.717M
Beta (5Y Monthly)1.64
PE Ratio (TTM)N/A
EPS (TTM)-1.74
Earnings DateFeb 19, 2025
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.00
  • PR Newswire

    BerGenBio Appoints Olav Hellebø as CEO

    BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced today the appointment of Olav Hellebø as CEO. Mr. Hellebø will assume the position on November 21, 2024.

  • PR Newswire

    BerGenBio Third Quarter Results 2024

    BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharma-ceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced financial results for the quarter and half year ended September 30, 2024, and provided a business update.